Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6a03166b3678f86a626aca60",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate formoterol fumarate and budesonide inhalation",
"description": "Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nWhen patients and healthcare providers search for a reliable inhalation therapy for chronic respiratory conditions, Glycopyrrolate + Formoterol Fumarate + Budesonide inhalation stands out as a modern triple-combination treatment designed to support long-term breathing management. This combination is commonly prescribed in patients requiring advanced maintenance therapy for chronic airway obstruction and inflammation.\nThe three active ingredients work together to help open the airways, reduce inflammation, and improve overall lung function. Triple-combination inhalation therapy is widely used in chronic respiratory management and is commonly prescribed for adults needing long-term control of airway symptoms. \nWhat is Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation?\nThis inhalation contains three clinically proven medicines:\n1. Glycopyrrolate\nGlycopyrrolate helps relax airway muscles by blocking muscarinic receptors. This action keeps air passages open for easier breathing.\n2. Formoterol Fumarate\nFormoterol is a long-acting bronchodilator that helps maintain airway relaxation for extended periods.\n3. Budesonide\nBudesonide reduces airway inflammation, swelling, and irritation, helping lower flare-ups in chronic respiratory disease.\nTogether, these three medicines create a comprehensive treatment option for respiratory maintenance therapy. \nKey Buyer Benefits of This Inhalation\nHealthcare professionals and procurement teams often choose this inhalation because of its multiple benefits:\nSuperior Triple Action\nInstead of prescribing multiple inhalers, this triple combination provides three therapeutic actions in one inhalation device.\nImproved Lung Function\nPatients may experience better airflow and improved breathing comfort with regular prescribed use.\nReduced Respiratory Flare-Ups\nClinical use shows that triple therapy can help reduce worsening episodes in chronic airway disease. \nBetter Patient Compliance\nA single inhaler may improve convenience and adherence to treatment plans.\nCommon Uses of Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nThis inhalation is commonly prescribed for:\n\n\nChronic Obstructive Pulmonary Disease (COPD)\n\n\nChronic bronchitis\n\n\nAirflow limitation disorders\n\n\nLong-term respiratory maintenance therapy\n\n\nPhysician-directed asthma maintenance in appropriate patients\n\n\nThis medicine is for maintenance treatment and is not intended for immediate relief of sudden breathing attacks. \nHow Does This Triple Combination Work?\nEach component contributes differently:\nGlycopyrrolate reduces airway tightening.\nFormoterol Fumarate keeps air passages open for longer periods.\nBudesonide controls airway inflammation.\nThis combined mechanism helps support easier breathing and better respiratory stability.\nWhy Buyers Choose This Product\nHospitals, distributors, pharmacies, and healthcare procurement teams often look for products that offer:\n\n\nHigh therapeutic value\n\n\nReliable respiratory support\n\n\nEasy inhalation administration\n\n\nReduced need for multiple inhalers\n\n\nStrong physician acceptance\n\n\nBecause this product combines anti-inflammatory and bronchodilator benefits, it remains a preferred respiratory care option.\nDosage and Administration\nThe exact dosage should always be prescribed by a healthcare professional.\nTypical maintenance inhalation regimens are taken twice daily depending on formulation and clinical need. Patients should rinse their mouth after use to help reduce local side effects. \nImportant Usage Tips\n\n\nShake inhaler before use\n\n\nUse exactly as prescribed\n\n\nDo not exceed recommended doses\n\n\nPrime inhaler if instructed\n\n\nStore in a cool and dry place\n\n\nPossible Side Effects\nLike all prescription medicines, some users may experience side effects such as:\n\n\nDry mouth\n\n\nThroat irritation\n\n\nHoarseness\n\n\nMild cough\n\n\nHeadache\n\n\nOral fungal infection\n\n\nFast heartbeat in some patients\n\n\nMost effects are manageable under medical supervision. \nSafety Precautions\nBefore using this inhalation, patients should inform their doctor if they have:\n\n\nHeart disease\n\n\nHigh blood pressure\n\n\nDiabetes\n\n\nThyroid disorders\n\n\nKidney problems\n\n\nLiver disease\n\n\nGlaucoma\n\n\nPregnant or breastfeeding patients should use it only under medical supervision.\nPackaging and Commercial Availability\nThis product is generally available in metered-dose inhaler packaging suitable for:\n\n\nHospitals\n\n\nMedical distributors\n\n\nExport buyers\n\n\nRetail pharmacies\n\n\nRespiratory specialty clinics\n\n\nBulk procurement options may be available depending on manufacturer and supply chain requirements.\nWhy This Inhalation is a Smart Healthcare Purchase\nFor medical buyers and respiratory specialists, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation offers:\n\n\nTriple mechanism support\n\n\nTrusted respiratory treatment profile\n\n\nStrong prescription demand\n\n\nGrowing market acceptance\n\n\nLong-term patient care utility\n\n\nConclusion\nIf you are searching for an advanced respiratory maintenance solution, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation delivers comprehensive airway support through bronchodilation and anti-inflammatory action. Whether for hospital procurement, pharmacy distribution, or physician prescribing needs, this triple-combination inhalation remains a high-demand therapeutic option in respiratory medicine.\n",
"price": 885.0,
"discountamount": 266.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2417,
"imageuri": "https://productimages.withfloats.com/actual/6a03166ee67a7c906d87cf8d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a03166ee67a7c906d87cf8d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-12T12:00:43.79Z",
"updatedon": "2026-06-04T07:57:03.191Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glycopyrrolate-formoterol-fumarate-and-budesonide-inhalation/2417",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDEPRESS PLUS INH",
"category": "ASTHMARANGE",
"tags": [
"glycopyrrolate formoterol fumarate and budesonide inhalation",
"buy budesonide glycopyrrolate formoterol fumarate",
"budesonide glycopyrrolate formoterol fumarate",
"glycopyrrolate formoterol fumarate",
"Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation",
"Buy Glycopyrrolate Formoterol Budesonide Inhaler Online",
"Triple Combination Inhaler for COPD Treatment",
"Asthma Treatment Inhaler with Budesonide and Formoterol",
"Budesonide Formoterol Glycopyrrolate Inhalation Therapy",
"Prescription Inhaler for COPD and Asthma Management",
"Glycopyrrolate Formoterol Budesonide Inhaler Product Image",
"Best Triple Therapy Inhaler for Breathing Disorders",
"Budesonide Glycopyrrolate Formoterol Inhaler for Lung Care",
"Budesonide, glycopyrrolate, formoterol brand name",
"glycopyrrolate formoterol fumarate and budesonide inhalation in hindi",
"glycopyrrolate formoterol fumarate and budesonide inhalation price",
"glycopyrrolate formoterol fumarate and budesonide inhalation price in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66d99766d075bc6e1b960947",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate glycopyrronium inhalation solution 25 mcg",
"description": "GLYCOPRESS \nglycopyrrolate glycopyrronium inhalation solution 25 mcg \nGLYCOPRESS™ is a precision-formulated inhalation solution containing 25 mcg of glycopyrrolate (also known as glycopyrronium), a long-acting bronchodilator designed to help individuals manage chronic respiratory conditions. Glycopyrrolate belongs to a class of medications known as long-acting muscarinic antagonists (LAMAs). These medicines work by relaxing the muscles surrounding the airways, allowing them to remain open for easier breathing.\n\nGLYCOPRESS™ is primarily prescribed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is intended for regular, long-term use and is delivered via a nebulizer system, ensuring consistent and controlled medication delivery directly into the lungs.\n\nThis inhalation solution is developed to provide sustained bronchodilation, improved airflow, and enhanced respiratory comfort for patients who require ongoing airway management.\n\nHow GLYCOPRESS™ Works\n\nThe active ingredient in GLYCOPRESS™, glycopyrrolate, works by blocking the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle. Acetylcholine is a neurotransmitter that causes airway muscles to constrict. By inhibiting its action, glycopyrrolate helps prevent bronchospasm (tightening of the airway muscles).\n\nThis mechanism results in:\n\nRelaxation of bronchial smooth muscles\n\nReduced airway resistance\n\nImproved airflow\n\nEasier breathing\n\nAs a long-acting bronchodilator, GLYCOPRESS™ provides sustained airway dilation, making it suitable for daily maintenance therapy rather than immediate relief of sudden breathing problems.\n\nIndications and Uses\n\nGLYCOPRESS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nManagement of chronic bronchitis\n\nManagement of emphysema\n\nLong-term bronchodilation therapy\n\nIt is important to note that GLYCOPRESS™ is not a rescue medication. It should not be used for sudden episodes of shortness of breath. Patients should continue to carry a fast-acting rescue inhaler for acute bronchospasm episodes.\n\nKey Benefits of GLYCOPRESS™\n1. Long-Lasting Bronchodilation\n\nGLYCOPRESS™ provides sustained airway relaxation, helping maintain open airways throughout the day when used as prescribed.\n\n2. Improved Breathing Comfort\n\nBy reducing airway constriction, patients often experience reduced shortness of breath, wheezing, and chest tightness.\n\n3. Enhanced Lung Function\n\nRegular use may lead to measurable improvements in lung capacity and airflow over time.\n\n4. Reduced Exacerbations\n\nConsistent bronchodilation can help lower the frequency and severity of COPD flare-ups.\n\n5. Convenient Nebulized Delivery\n\nThe inhalation solution format ensures medication reaches deep into the lungs, especially beneficial for patients who struggle with handheld inhalers.\n\n6. Targeted Action\n\nBecause the medication is inhaled directly into the lungs, systemic exposure is minimized compared to oral medications, potentially reducing widespread side effects.\n\n7. Non-Steroidal Option\n\nGLYCOPRESS™ does not contain corticosteroids, making it suitable for patients seeking bronchodilation without steroid exposure.\n\nDosage and Administration\n\nGLYCOPRESS™ (25 mcg) should be used exactly as prescribed by a healthcare professional. The inhalation solution is administered via a standard nebulizer device.\n\nGeneral usage guidelines:\n\nUse at the same time each day.\n\nDo not exceed the prescribed dose.\n\nDo not swallow the solution.\n\nRinse the mouth after inhalation if advised by your healthcare provider.\n\nClean the nebulizer equipment after each use to maintain hygiene and prevent contamination.\n\nPatients should never abruptly discontinue therapy without consulting their healthcare provider.\n\nPossible Side Effects\n\nLike all medications, GLYCOPRESS™ may cause side effects. While many patients tolerate glycopyrrolate well, some may experience mild to moderate reactions.\n\nCommon Side Effects\n\nDry mouth\n\nThroat irritation\n\nCough\n\nHeadache\n\nNasal congestion\n\nMild dizziness\n\nThese effects are usually manageable and may decrease as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nDifficulty urinating\n\nBlurred vision\n\nIncreased heart rate (tachycardia)\n\nWorsening of glaucoma symptoms\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nPatients with a history of narrow-angle glaucoma, urinary retention, or prostate enlargement should use GLYCOPRESS™ with caution and under medical supervision.\n\nIf sudden worsening of breathing occurs immediately after use (paradoxical bronchospasm), discontinue the medication and seek medical attention immediately.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS™, inform your healthcare provider if you:\n\nHave glaucoma\n\nHave urinary retention issues\n\nHave prostate enlargement\n\nHave kidney problems\n\nAre pregnant or breastfeeding\n\nAre using other anticholinergic medications\n\nDrug interactions may occur when used alongside other anticholinergic drugs, potentially increasing side effects such as dry mouth or urinary retention.\n\nGLYCOPRESS™ should be stored at room temperature and kept away from direct sunlight and moisture. Keep out of reach of children.\n\nWho Should Use GLYCOPRESS™?\n\nGLYCOPRESS™ is suitable for adults diagnosed with chronic obstructive pulmonary disease who require consistent, long-term airway management. It is particularly beneficial for:\n\nPatients who experience persistent daily symptoms\n\nIndividuals who require nebulized medication delivery\n\nPatients needing a non-steroidal maintenance bronchodilator\n\nThose seeking improved respiratory stability and quality of life\n\nIt is not recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nQuality and Reliability\n\nGLYCOPRESS™ is manufactured under strict pharmaceutical quality standards to ensure consistent dosing accuracy, sterility, and safety. Each 25 mcg dose is carefully formulated to deliver precise bronchodilation while minimizing systemic absorption.\n\nIts inhalation solution format ensures even dispersion and efficient lung deposition when used with an appropriate nebulizer system.\n\nLifestyle Support with GLYCOPRESS™\n\nWhile GLYCOPRESS™ plays a critical role in COPD management, optimal results are achieved when combined with:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular exercise as advised\n\nBalanced nutrition\n\nRoutine medical follow-up\nPatients are encouraged to monitor symptoms regularly and maintain open communication with their healthcare provider.\nConclusion\nGLYCOPRESS™ (Glycopyrrolate / Glycopyrronium Inhalation Solution 25 mcg) represents a reliable, long-acting bronchodilator option for individuals managing chronic obstructive pulmonary disease. By targeting airway muscle constriction at its source, GLYCOPRESS™ promotes sustained bronchodilation, improved airflow, and enhanced breathing comfort.",
"price": 2250.0,
"discountamount": 675.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"2 ml",
"1 ml",
"25 mcg",
"Dry Mouth",
"single dose",
"fast relief",
"gut motility",
"higher doses",
"stomach acid",
"Key Benefits",
"clear airways",
"long-term use",
"bodily fluids",
"natural fluids",
"rare instances",
"potential risks",
"fast heart rate",
"mucus production",
"Preoperative Use",
"saliva production",
"Glycopyrrolate IP",
"Urinary Retention",
"clinical settings",
"saliva substitutes",
"specific condition",
"healthcare provider",
"common side effects",
"respiratory diseases",
"muscarinic receptors",
"glandular secretions",
"Respiratory Function",
"excessive secretions",
"Increased Heart Rate",
"optimal effectiveness",
"2ml isotonic solution",
"Isotonic solution 2ml",
"respiratory conditions",
"Convenient Dosage Form",
"anticholinergic effects",
"intramuscular injection",
"healthcare professional",
"other bodily secretions",
"effective administration",
"Temporary blurred vision",
"various medical conditions",
"specialized pharmaceutical solution"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1970,
"imageuri": "https://productimages.withfloats.com/actual/66d99795d84b3a29c4a85529.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66d99795d84b3a29c4a85529.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-05T11:35:02.018Z",
"updatedon": "2026-04-08T09:01:49.567Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glycopyrrolate-glycopyrronium-inhalation-solution-25-mcg/1970",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLYCOPRESS ",
"category": "ASTHMARANGE",
"tags": [
"glycopyrrolate glycopyrronium inhalation solution 25 mcg single dose vial",
"glycopyrrolate glycopyrronium 25 mcg nebulizer solution for COPD",
"glycopyrrolate 25 mcg inhalation solution unit dose ampule",
"glycopyrrolate 25 mcg nebulized bronchodilator therapy",
"glycopyrrolate inhalation 25 mcg dosing instructions",
"glycopyrrolate 25 mcg inhalation solution prescribing information",
"what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for",
"what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for",
"is glycopyrronium 25 mcg inhalation solution safe for COPD",
"can glycopyrrolate 25 mcg inhalation solution cause dry mouth",
"buy glycopyrrolate glycopyrronium inhalation solution 25 mcg online"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6630c1a164366d22740b6199",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "INH AIRFLOW 250 ",
"description": "Managing chronic respiratory conditions like asthma and COPD requires a reliable, long-term treatment approach. INH AIRFLOW 250 by Steris Healthcare Pvt. Ltd. is a clinically trusted inhalation therapy designed to provide effective control over airway inflammation and bronchoconstriction. With a powerful dual-action combination of Fluticasone Propionate and Salmeterol, this inhaler helps patients breathe easier and live more actively.\n\nWhat is INH AIRFLOW 250?\nINH AIRFLOW 250 is a combination inhaler formulated with:\n\n\nFluticasone Propionate IP 250 mcg – a corticosteroid that reduces inflammation in the airways\n\n\nSalmeterol Xinafoate IP 25 mcg – a long-acting bronchodilator that helps keep airways open\n\n\nThis combination therapy is widely prescribed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It works by targeting both the underlying inflammation and airway narrowing, ensuring comprehensive respiratory care.\n\nHow INH AIRFLOW 250 Works\nINH AIRFLOW 250 works through a dual mechanism that ensures better breathing control:\n1. Anti-Inflammatory Action\nFluticasone Propionate helps reduce swelling, irritation, and mucus production in the airways. This decreases the frequency and severity of asthma attacks.\n2. Bronchodilation\nSalmeterol relaxes the muscles surrounding the airways, allowing them to widen and making it easier for air to flow in and out of the lungs.\nTogether, these actions help prevent symptoms like wheezing, breathlessness, chest tightness, and coughing.\n\nKey Benefits of INH AIRFLOW 250\n\n\nEffective asthma control – Reduces frequency of asthma attacks\n\n\nLong-lasting relief – Provides extended bronchodilation for up to 12 hours\n\n\nImproves lung function – Enhances breathing capacity and oxygen flow\n\n\nPrevents exacerbations – Helps reduce sudden worsening of symptoms\n\n\nConvenient inhalation therapy – Direct delivery to lungs for faster action\n\n\nSuitable for maintenance therapy – Ideal for long-term use under medical supervision\n\n\n\nIndications of INH AIRFLOW 250\nINH AIRFLOW 250 is indicated for:\n\n\nBronchial Asthma (moderate to severe cases)\n\n\nChronic Obstructive Pulmonary Disease (COPD)\n\n\nLong-term prevention of respiratory symptoms\n\n\nMaintenance therapy for patients requiring combination inhalers\n\n\nIt is important to note that this inhaler is not intended for immediate relief of acute asthma attacks. Patients should always carry a rescue inhaler for emergencies.\n\nDosage and Administration\n\n\nUse INH AIRFLOW 250 exactly as prescribed by your healthcare professional\n\n\nTypically, it is administered twice daily (morning and evening)\n\n\nInhale the medication deeply through the mouth using the inhaler device\n\n\nRinse your mouth after each use to reduce the risk of oral infections\n\n\nTip: Proper inhalation technique is essential for maximum effectiveness. Patients should be guided by a healthcare provider on correct usage.\n\nPossible Side Effects\nLike all medications, INH AIRFLOW 250 may cause some side effects, although not everyone experiences them.\nCommon Side Effects:\n\n\nThroat irritation\n\n\nHoarseness of voice\n\n\nOral fungal infections (thrush)\n\n\nHeadache\n\n\nLess Common but Serious Effects:\n\n\nIncreased heart rate\n\n\nMuscle cramps\n\n\nAllergic reactions\n\n\nWorsening breathing symptoms (rare)\n\n\nIf any severe or persistent side effects occur, medical advice should be sought immediately.\n\nPrecautions and Warnings\n\n\nNot recommended for patients with known hypersensitivity to any of the ingredients\n\n\nUse with caution in patients with heart disease, diabetes, or thyroid disorders\n\n\nPregnant and breastfeeding women should consult a doctor before use\n\n\nAvoid exceeding the prescribed dose\n\n\nAlways rinse mouth after inhalation to prevent infections\n\n\n\nDrug Interactions\nINH AIRFLOW 250 may interact with certain medications, including:\n\n\nBeta-blockers\n\n\nAntifungal drugs (like ketoconazole)\n\n\nHIV protease inhibitors\n\n\nOther corticosteroids\n\n\nPatients should inform their doctor about all medications they are currently taking.\n\nStorage Instructions\n\n\nStore in a cool and dry place\n\n\nKeep away from direct sunlight and heat\n\n\nKeep out of reach of children\n\n\nDo not puncture or expose the inhaler to high temperatures\n\n\n\nWhy Choose INH AIRFLOW 250?\nINH AIRFLOW 250 is developed with a patient-centric approach, ensuring safety, efficacy, and convenience. It offers:\n\n\nTrusted dual therapy formulation\n\n\nConsistent dose delivery system\n\n\nImproved patient compliance\n\n\nBacked by Steris Healthcare quality standards\n\n\nFor patients struggling with persistent asthma or COPD symptoms, INH AIRFLOW 250 provides a dependable solution for long-term respiratory management.\n\nFrequently Asked Questions (FAQs)\n1. What is INH AIRFLOW 250 used for?\nIt is used for the maintenance treatment of asthma and COPD, helping to control symptoms and improve breathing.\n2. Can INH AIRFLOW 250 be used during an asthma attack?\nNo, it is not a rescue inhaler. It is meant for long-term control, not immediate relief.\n3. How long does it take to show results?\nSome improvement may be noticed within a few days, but full benefits are usually seen after regular use over a few weeks.\n4. Is it safe for long-term use?\nYes, when used as prescribed by a doctor, it is safe and effective for long-term management.\n5. Do I need to rinse my mouth after using it?\nYes, rinsing helps prevent oral infections like fungal growth.\n\nConclusion\nINH AIRFLOW 250 (Fluticasone Propionate IP 250 mcg + Salmeterol Xinafoate IP 25 mcg) is a highly effective inhalation therapy designed to provide long-lasting relief from asthma and COPD symptoms. By combining anti-inflammatory and bronchodilator actions, it ensures better breathing control and improved quality of life.\nFor patients seeking a reliable and advanced respiratory solution, INH AIRFLOW 250 stands out as a trusted choice from Steris Healthcare Pvt. Ltd. Always consult your healthcare provider before starting or changing any medication to ensure optimal results and safety.",
"price": 532.0,
"discountamount": 160.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"risk",
"lungs",
"doctor",
"adults",
"muscles",
"control",
"airways",
"coughing",
"wheezing",
"symptoms",
"concerns",
"children",
"shortness",
"flare-ups",
"breathing",
"Salmeterol",
"Fluticasone",
"INH AIRFLOW",
"inflammation",
"interactions",
"asthma attacks",
"inhaler device",
"corticosteroid",
"chest tightness",
"other medications",
"COPD exacerbations",
"dosage adjustments",
"acting beta agonist",
"respiratory condition",
"maintenance treatment",
"combination medication",
"potential side effects",
"healthcare professional",
"proper usage instructions",
"chronic obstructive pulmonary disease"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 888,
"imageuri": "https://productimages.withfloats.com/actual/6630c1a4705a96ecc7c694a1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6630c1a4705a96ecc7c694a1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-30T10:02:09.455Z",
"updatedon": "2026-04-17T10:59:21.888Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//inh-airflow-250-/888",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Salmeterol 50mg, Fluticasone 250mg",
"category": "ASTHMARANGE",
"tags": [
"Fluticasone Propionate IP 250 mcg + Salmeterol Xinafoate IP 25 mcg inhaler uses",
"Fluticasone 250 mcg + Salmeterol 25 mcg dosage guide"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6def248b0777b5cb29791c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Propranolol Hydrochloride Sustained Release Capsules IP",
"description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.",
"price": 45.0,
"discountamount": 14.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2490,
"imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:05:40.676Z",
"updatedon": "2026-08-01T13:05:40.676Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PROPASULES LA 40",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6dedd85b0d81b5d5e65e09",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Olanzapine Mouth Dissolving Tablets 2.5 mg",
"description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.",
"price": 60.0,
"discountamount": 18.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2489,
"imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:00:08.65Z",
"updatedon": "2026-08-01T13:00:08.65Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLANZPRIME 2.5",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6dec4d7747964c2eea9a0f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets",
"description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.",
"price": 248.0,
"discountamount": 75.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2488,
"imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T12:53:33.409Z",
"updatedon": "2026-08-01T12:53:33.409Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METAPROLATE H 50/12.5",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a685f3a5315456e18559082",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Acebrophylline and Erdosteine Tablets",
"description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2487,
"imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-28T07:50:18.551Z",
"updatedon": "2026-07-28T07:50:18.551Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//acebrophylline-and-erdosteine-tablets/2487",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STERIPHYLLIN ERDO",
"category": "ASTHMA RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}